Skip to main content
. 2024 Nov 4;16:17588359241293951. doi: 10.1177/17588359241293951

Figure 2.

Figure 2.

L1CAM upregulation correlates with worse OS in ASPS patients. The high L1CAM expression group presents a median OS of 27.0 months (95% CI 22.8–31.2) compared to 151 months (95% CI NR) of patients with low L1CAM expression (p-value = 0.011). Kaplan–Meier curves represent all patients in the cohort with available biological samples (n = 17).

ASPS, alveolar soft-part sarcoma; CI, confidence interval; OS, overall survival.